All In MedTech

Device Trial Radar · NCT07432191

Medical Device Clinical Trial Without CE Marking to Evidence Safety and Performance of the INBENTUS VERSATILE Ventilator in Patients Requiring Assisted/Controlled Mechanical Ventilation and Weaning.

Last checked: Nov 20, 2026Latest source record: Sep 14, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

81

Planned (sponsor's estimate)

Start

May 29, 2025

Primary completion

Dec 2026

Study completion Dec 2026

Sponsor

Lead sponsor
Iconic Solutions By Murcia SLNot on our public-company list
Sponsor type
Industry
Collaborators
Hospital Universitario Virgen de la Arrixaca; Iberania Contract Research
First posted
Feb 25, 2026

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Supportive care
FDA-regulated device
No
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Pre-market clinical trial on 81 aldults participants to evidence safety and performance of the non-CE-marked medical device INBENTUS VERSATILE ventilator. The 81 aldult participants are ventilated between 3 and 48 hours with invasive mechanical ventilation (IMV) in assisted/controlled mode and weaning under partial pressure support or volume support, followed by monitoring period until ICU discharge, hospital discharge or 30 days. The study design differentiates between a Validation Cohort (up to 20 participants) for device validation and a Study Cohort (up to 61 participants) for safety and performance confirmation. Serious Adverse Events related to study device and/or its procedure is defined as the primary safety endpoint, whereas technical failure rate is defined as the primary performance endpoint.

Conditions

  • Acute Respiratory Distress Syndrome (ARDS)
  • Pneumonia
  • COPD (Chronic Obstructive Pulmonary Disease)
  • Postoperative Respiratory Distress
  • Hypoventilation Syndrome
  • Hypoxemia
  • Hypercapnia

Interventions

  • INBENTUS VERSATILEDevice

    INBENTUS VERSATILE ventilation according to protocol specifications and clinical needs

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Primary Safety EndpointTime frame: From 3 to 48 hours of mechanical ventilation under the study device

1 more outcomes with a free account

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Hospital Universitario Virgen de la Arrixaca

    Murcia, Spain · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.